FDC
Back to Cashflow Statement
|
FDC Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-92 Cr | ₹-202 Cr | ₹-180 Cr | ₹-9.84 Cr | ₹-129 Cr |
What is the latest Cash Flow from Financing Activities ratio of FDC ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-92 Cr |
Mar2024 | ₹-202 Cr |
Mar2023 | ₹-180 Cr |
Mar2022 | ₹-9.84 Cr |
Mar2021 | ₹-129 Cr |
How is Cash Flow from Financing Activities of FDC Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-92 Cr | Negative | |
Mar2024 | ₹-202 Cr | Negative | |
Mar2023 | ₹-180 Cr | Negative | |
Mar2022 | ₹-9.84 Cr | Negative | |
Mar2021 | ₹-129 Cr | - |
Compare Cash Flow from Financing Activities of peers of FDC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
FDC | ₹7,297.5 Cr | 2.8% | -7.8% | -20.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,560.0 Cr | 2.2% | 2.1% | -10.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,033.0 Cr | 0.3% | 6.4% | 8.7% | Stock Analytics | |
CIPLA | ₹134,400.0 Cr | 6.8% | 5.6% | 5.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,507.0 Cr | 1.6% | -1.1% | 5.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,628.0 Cr | 4.6% | -2.5% | -4.3% | Stock Analytics |
FDC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FDC | 2.8% |
-7.8% |
-20.3% |
SENSEX | 2.9% |
1.7% |
3.6% |
You may also like the below Video Courses